![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
Pmc Biogenix, Inc. Memphis Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Oleic Acid, Kemamide® W20, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2001-011 - Rev 01
This TSE Type CEP, issued on February 06, 2009, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 799 associated with this CEP further emphasizes